J&J quarterly profit beats on pharmaceuticals strength

(Reuters) - Johnson & Johnson beat estimates for fourth-quarter profit on Tuesday as increased sales of pharmaceutical products helped it weather a hit from a stronger dollar

Excluding items, J&J earned $2.35 per share, above analysts' average estimates of $2.23 per share, according to IBES data from Refinitiv.

(Reporting by Manas Mishra and Bhanvi Satija in Bengaluru; Editing by Anil D'Silva)